RE:Products Submitted for Certain Markets ...If GBT R&D does not provide any new developing dugs for latam and other makrets in a Year or two GUD is going now where for a long time. It is up to GUD to inform the market in a month or two if they have are new drugs in the pipleline. If they do not talk about it means GBT does not have any new drugs in the pipeline. They have spend money on R&D but for what? Reproducing old generic drugs or developing new ones? I do not know
The market will discount GUD/GBT potentials as their market in LATAM is a difficult one to navigate at best even for an insider operator. Did JG blink? If GBT does not have new drugs in the pipelne he has blinked and bad. Time will tell. Selling generics drugs is hopeless for profits but a good charity cause for those countries and the people. As usual I hope for the best.